Page 32 - Pharma Services News Today

NeoGenomics (NASDAQ:NEO – Get Rating) released its quarterly earnings results on Wednesday. The medical research company reported ($0.20) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.24) by $0.04, Briefing.com reports. NeoGenomics had a negative net margin of 7.33% and a negative return on equity of 6.62%. The company had revenue of $117.17 […]

First-Quarter 2022 ResultsConsolidated revenue increased 1% to $117 million; excluding 2021 COVID-19 PCR testing revenue, consolidated revenue increased 3%Clinical Services revenue increased 2% to $99

27.04.2022 - First-Quarter 2022 ResultsConsolidated revenue increased 1% to $117 million; excluding 2021 COVID-19 PCR testing revenue, consolidated revenue increased 3%Clinical Services revenue increased 2% to $99 million; excluding 2021 COVID-19 PCR testing ...

04/19/22 Pharmaceutical Online Newsletter

NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) was the recipient of a large decrease in short interest in March. As of March 31st, there was short interest totalling 5,220,000 shares, a decrease of 27.3% from the March 15th total of 7,180,000 shares. Based on an average trading volume of 1,870,000 shares, the short-interest ratio is currently […]

NeoGenomics (NASDAQ:NEO – Get Rating) was upgraded by StockNews.com to a “sell” rating in a research note issued to investors on Saturday. Several other research analysts have also commented on NEO. Zacks Investment Research upgraded shares of NeoGenomics from a “sell” rating to a “hold” rating in a research note on Friday, March 4th. Morgan […]

Equities analysts expect NeoGenomics, Inc. (NASDAQ:NEO – Get Rating) to post earnings per share (EPS) of ($0.19) for the current quarter, according to Zacks. Four analysts have provided estimates for NeoGenomics’ earnings, with estimates ranging from ($0.27) to ($0.10). NeoGenomics reported earnings per share of ($0.04) in the same quarter last year, which suggests a […]

April 11, 2022 NeoGenomics, Inc. Expands Its Global Strategic Partnership Initiatives with Biognosys AG on Multiple Next Generation Proteomics Solutions... | April 11, 2022

INCOG BioPharma Services (“INCOG”), an Indiana-based contract development and manufacturing organization (CDMO) reached another major...

04/07/22 Pharmaceutical Online Newsletter